K. Beckett

A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice

R. Khanna, S. Horsefield, George R. Ambalathingal, 2022, bioRxiv.

Eomesodermin promotes the development of type 1 regulatory T (TR1) cells

S. McColl, G. Belz, M. Degli-Esposti, 2017, Science Immunology.

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia

F. Al-Ejeh, A. Boyd, C. Bruedigam, 2015, PloS one.

Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice

R. Khanna, C. Haqq, P. DeMuth, 2023, Nature communications.